Geron GERN Chemistry, manufacturing, and control expenses — R&D

Similar metrics at other companies

MPLTChemistry Manufacturing And Controls Expenses — Research And Development Expense

$6.42M+62.2%

NRIXInternal research and development expenses — R&D

$57.07M+12.2%

MPLTClinical Trial — Research And Development Expense

$24.82M+1,180%

BCRXResearch, discovery and preclinical programs — Research and Development Expense (Excluding Acquired in Process Cost)

$3.97M+30.4%

DBVTExpenses by function — Research and development expense

$8.5M+84.8%

MPLTPreclinical Program — Research And Development Expense

$5.52M-9.2%

Questions, answered.

What is Geron's chemistry, manufacturing, and control expenses — R&D?

Geron (GERN) reported chemistry, manufacturing, and control expenses — R&D of $600K in Q1 2026.

How has Geron's chemistry, manufacturing, and control expenses — R&D changed year-over-year?

Geron's chemistry, manufacturing, and control expenses — R&D decreased by 60.0% year-over-year, from $1.5M to $600K.

What does chemistry, manufacturing, and control expenses — R&D mean?

This metric represents the costs associated with the development, scale-up, and quality assurance of manufacturing processes for clinical-stage drug candidates. It encompasses activities required to ensure pharmaceutical products meet regulatory standards for purity, stability, and consistency during the research and development phase. Monitoring these expenses provides insight into the company's investment in supply chain readiness and the technical feasibility of transitioning drug candidates from clinical trials to commercial production.